The peer-reviewed article reports results from a randomized, double-blind, placebo-controlled trial evaluating CardiolRx™, Cardiol's lead oral drug candidate, in 109 patients with acute myocarditis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results